SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling.
Pankaj DwivediSomchai ChutipongtanateDavid E MuenchMohammad AzamHarry Leighton GrimesKenneth D GreisPublished in: Proteomics. Clinical applications (2020)
This robust dataset is available for further mining, hypothesis generation, and testing. A detailed understanding of the restructuring of the proteomics signaling cascades by ibrutinib in leukemia biology will provide new avenues to explore its use for other related malignancies.